Dissecting acral melanoma cell state-specific vulnerabilities for targeted intervention

Active Project Grant Awarded Last action

Award ID
HT9425261E357
Recipient
Awarding agency
Obligated
$560,000

Award facts

Assistance listing
12.420 Military Medical Research and Development
Completion date 10% complete
Place of performance
Philadelphia, PA 19104, USA

Award details come from USAspending.gov.

About this award

Written by GovTribe AI ·

The Defense Health Agency awarded The Wistar Institute of Anatomy and Biology $560,000 on August 15, 2026, under the Military Medical Research and Development program (CFDA 12.420) to conduct research dissecting acral melanoma cell state-specific vulnerabilities for targeted intervention. Work is performed in Philadelphia, Pennsylvania, with a period of performance through August 14, 2028. The award funds basic and translational biomedical research in melanoma immunotherapy, aligning with the Defense Health Agency's mission to investigate medical solutions relevant to military health care. Wistar acts as the prime recipient of this Project Grant assistance type within its broader portfolio of federally-funded cancer immunology and HIV immunotherapy research.

Quick answers

Who received award HT9425261E357?

HT9425261E357 was awarded to The Wistar Institute Of Anatomy And Biology by Defense Health Agency (Department of Defense) on August 15, 2026.

How much is award HT9425261E357 worth?

$560,000 has been obligated on HT9425261E357.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award
Try for free Login